By Kate Foster, Health Editor For The Scottish Daily Mail
Published: 12:26 BST, 23 April 2019 | Updated: 12:26 BST, 23 April 2019
View
comments
Breast cancer patient Lee Dennis, one of those who received a lower dose of breast cancer drugs, called for 'trust' to be restored between doctors and patients at the trust
Two health board consultants are being investigated by a medical watchdog.
The General Medical Council (GMC) has launched a probe into women being prescribed lower doses of chemotherapy than they should have been.
The GMC, which regulates doctors, is investigating the prescribing of breast cancer drugs at NHS Tayside.
The review is understood to be examining the conduct of two doctors involved in the care of more than 300 patients.
A total of 14 women, who were treated between December 2016 and March 2019, have since died.
The doctors prescribed lower doses of breast cancer drug docetaxel in an attempt to reduce serious side-effects and long-lasting secondary conditions.
A Healthcare Improvement Scotland (HIS) report found the dosage given to Tayside patients was lower than in any other health board area and that patients were not told of the variance.
A GMC spokesman said: ‘We are aware of the concerns in Healthcare Improvement Scotland’s report and will carefully consider any issues raised against the professional standards we expect of doctors.’
Senior Tayside clinicians have
